Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
Phase 4
Completed
- Conditions
- Cardiovascular DiseaseIschemic Heart Disease
- Interventions
- Drug: placebo
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 95
- Registration Number
- NCT01295567
- Locations
- 🇳🇱
RUNMC, Nijmegen, Netherlands
Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer
Not Applicable
- Conditions
- Colorectal Cancer
- Interventions
- Other: Multi-modality imaging
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01292681
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients
Phase 2
- Conditions
- Breast Cancer
- Interventions
- Drug: Hydrochloroquine
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01292408
- Locations
- 🇳🇱
University Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands
Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
Phase 1
Completed
- Conditions
- HCV InfectionsHIV Infections
- Interventions
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01288417
- Locations
- 🇳🇱
CRCN, Nijmegen, Netherlands
The Effect of Anakinra on Insulin Secretion
Not Applicable
- Conditions
- Impaired Insulin SecretionGlucose IntoleranceDiabetes Mellitus Type 2
- Interventions
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01285232
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01285245
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Efficacy and Safety of Canakinumab in Schnitzler Syndrome
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT01276522
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal Cancer
Phase 2
Completed
- Conditions
- Rectal Tumour
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT01273051
- Locations
- 🇳🇱
Academisch Medisch Centrum, Amsterdam, Netherlands
🇳🇱Slotervaart Ziekenhuis, Amsterdam, Netherlands
🇳🇱Amphia Ziekenhuis, Breda, Netherlands
In Hospital Care and Welfare Standard
Not Applicable
Completed
- Conditions
- Functional Decline and Complications of Frail Older Patients Admitted to Hospital
- Interventions
- Other: CWS in Hospital
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 404
- Registration Number
- NCT01273116
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Phase 3
- Conditions
- Candidemia
- Interventions
- Drug: Interferon-gamma, Recombinant
- First Posted Date
- 2011-01-05
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01270490
- Locations
- 🇳🇱
Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath